Zobrazeno 1 - 10
of 30
pro vyhledávání: '"C J, Van der Woude"'
Autor:
J Jansen, L J T Smits, R W M Pauwels, W Kievit, D J de Jong, A C de Vries, F Hoentjen, C J van der Woude, A.A. van Bodegraven, A.G.L. Bodelier, P.J. Boekema, N. de Boer, P.C.J. ter Borg, A.A. den Broeder, I.A.M Gisbertz, F.M Jansen, S.V. Jansen, D.J. de Jong, W. Kievit, R.C.A. van Linschoten, M Löwenberg, M.W.M.D. Lutgens, R.C. Mallant-Hent, A.E. van der Meulen, B. Oldenburg, R.W.M. Pauwels, M Pierik, M.J.L. Romberg-Camps, T.E.H. Römkens, M.G.V.M. Russel, L.J.T. Smits, A.C.I.T.L. Tan, M.L. Verhulst, A.C. de Vries, R.L. West, F.H.J. Wolfhagen, C.J. van der Woude
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
Introduction Adalimumab is effective for maintenance of remission in patients with Crohn’s disease (CD) at a dose of 40 mg subcutaneously every 2 weeks. However, adalimumab is associated with (long-term) adverse events and is costly. The aim of thi
Externí odkaz:
https://doaj.org/article/137bae053ba5412d9dec48e602f720d7
Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-8 (2017)
Abstract Background The role of single nucleotide polymorphisms (SNPs) associated with inflammatory bowel disease (IBD) is gaining interest. With the advent of novel therapies, personalized treatment in IBD is a future goal. We wondered whether IBD-a
Externí odkaz:
https://doaj.org/article/020e667f106a4ef9a58bdf7631936b9e
Autor:
R. L. Goetgebuer, C. J. van der Woude, L. Bakker, A. A. van der Eijk, L. de Ridder, A. C. de Vries
Publikováno v:
Scandinavian Journal of Gastroenterology, 57(11), 1321-1326. Informa Healthcare
Scandinavian journal of gastroenterology, 57(11), 1321-1326. Informa Healthcare
Scandinavian journal of gastroenterology, 57(11), 1321-1326. Informa Healthcare
Clinical guidelines on cytomegalovirus (CMV) colitis in inflammatory bowel disease (IBD) are hampered by the low quality of evidence. In this study, we aim to explore the attitude and management of CMV colitis in IBD among gastroenterologists. A web-
Publikováno v:
Alimentary Pharmacology & Therapeutics, 57(9), 1030-1031. Wiley-Blackwell Publishing Ltd
Autor:
R. S. Dwarkasing, E. J. R. de Graaf, W. R. Schouten, A. C. de Vries, C J van der Woude, H. P. Stevens, J. H. C. Arkenbosch, O. van Ruler, Gwenny M. Fuhler
Publikováno v:
Techniques in Coloproctology
Techniques in Coloproctology, 25(12), 1301-1309. Springer-Verlag Italia
Techniques in Coloproctology, 25(12), 1301-1309. Springer-Verlag Italia
Background Transanal advancement flap repair of transsphincteric fistulas is a sphincter-preserving procedure, which frequently fails, probably due to ongoing inflammation in the remaining fistula tract. Adipose-derived stromal vascular fraction (SVF
Autor:
R Van Linschoten, A S Huberts, N van Leeuwen, J A Hazelzet, C J van der Woude, R L West, D van Noord
Publikováno v:
Journal of Crohn's and Colitis. 17:i374-i375
Background The International Consortium for Health Outcomes Measurement (ICHOM) has defined a standard set of outcome measures for inflammatory bowel disease (IBD) to capture effectiveness of care delivery processes by systematic collection of outcom
Publikováno v:
Journal of Crohn's and Colitis. 17:i34-i35
Background Treatment of IBD has improved with the introduction of biologics and small molecules, yet this has come with a considerable increase in healthcare costs. Due to the increasing cost burden, reliable nationwide epidemiological data on the pr
Autor:
N Van De Pol, C J van der Woude, M Vis, M B A van Doorn, L A A P Derikx, I Molendijk, A C de Vries
Publikováno v:
Journal of Crohn's and Colitis. 17:i856-i857
Background Patients with Immune Mediated Inflammatory Diseases (IMIDs) treated with immunosuppressive drugs are at an increased risk of infections and a more complicated course of the infection, including vaccine-preventable infections. National and
Publikováno v:
Journal of Crohn's and Colitis. 17:i960-i961
Background Patients with inflammatory bowel disease (IBD) have reduced seroconversion rates to COVID-19 vaccination. It is unclear whether an impaired immune response in vaccinated IBD patients impacts the susceptibility to SARS-CoV-2 infection and o
Autor:
Natalia Pedersen, A Bar-Gil Shitrit, Shaji Sebastian, C J van der Woude, A De Lima-Karagiannis, Pascal Juillerat
Publikováno v:
Journal of Crohn's & Colitis
Journal of Crohns and Colitis
Journal of Crohn's and Colitis, 14, S807-S814. Oxford University Press
Journal of Crohns and Colitis
Journal of Crohn's and Colitis, 14, S807-S814. Oxford University Press
The rapid emergence of the novel coronavirus [SARS-CoV2] and the coronavirus disease 2019 [COVID-19] has caused significant global morbidity and mortality. This is particularly concerning for vulnerable groups such as pregnant women with inflammatory